Munakata, Wataru http://orcid.org/0000-0002-4679-0656
Ando, Kiyoshi
Yokoyama, Masahiro
Fukuhara, Noriko
Yamamoto, Kazuhito
Fukuhara, Suguru
Ohmachi, Ken
Mishima, Yuko
Ichikawa, Satoshi
Ogiya, Daisuke
Aoi, Arata
Hatsumichi, Masahiro
Tobinai, Kensei
Funding for this research was provided by:
Ono Pharmaceutical Co., Ltd., Osaka, Japan
Article History
Received: 11 July 2022
Revised: 6 December 2022
Accepted: 7 December 2022
First Online: 28 December 2022
Declarations
:
: Wataru Munakata reports research funds from Ono Pharmaceutical Co., Ltd. Kiyoshi Ando reports research funds from Celgene K.K., Novartis Pharma K.K., and Astellas Pharma Inc.; and scholarship endowments from Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Kyowa Kirin Co., Ltd. Masahiro Yokoyama reports acting as a medical adviser for Chugai Pharmaceutical Co., Ltd. Noriko Fukuhara reports lecture fees, honoraria, or other personal fees from SymBio Pharmaceuticals Ltd., Chugai Pharmaceutical Co., Ltd., and HUYA Bioscience International LLC; and research funds from Incyte Japan, Genmab K.K., Celgene K.K., Chugai Pharmaceutical Co., Ltd., and Bayer Yakuhin, Ltd. Kazuhito Yamamoto reports lecture fees, honoraria, or other personal fees from AbbVie GK, Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Meiji Seika Pharma Co., Ltd., Micron Inc., and Takeda Pharmaceutical Co., Ltd.; and research funds from Symbio Pharmaceuticals Ltd. and Yakult Honsha Co., Ltd. Suguru Fukuhara reports research funds from Chugai Pharmaceutical Co., Ltd. Ken Ohmachi has nothing to report. Yuko Mishima reports holding shares or share options in Chugai Pharmaceutical Co., Ltd.; and research funds from Takeda Pharmaceutical Co., Ltd., Bristol-Myers Squibb K.K., Eisai Co., Ltd., Kyowa Kirin Co., Ltd., and Taiho Pharmaceutical Co., Ltd. Satoshi Ichikawa reports research funds from AstraZeneca K.K. and BeiGene Japan. Daisuke Ogiya has nothing to report. Arata Aoi is an employee of Ono Pharma USA, Inc. Masahiro Hatsumichi is an employee of Ono Pharmaceutical Co., Ltd. Kensei Tobinai reports lecture fees, honoraria, or other personal fees from Zenyaku Kogyo Co., Ltd., HUYA Bioscience International LLC, Daiichi Sankyo Co., Ltd., and SymBio Pharmaceutical Ltd.